Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Christoph F. Ebenbichler, MD
JCP
Letter to the Editor
Is Second-Generation Antipsychotic-Induced Hyperprolactinemia Due to Biologically Active Prolactin or to Biologically Inactive Macroprolactin? Results From a Prospective Study
February 16, 2009
Alexander Tschoner
,
Julia Engl
,
Maria A. Rettenbacher
, et al
JCP
Original Research
Effect of Mirtazapine Treatment on Body Composition and Metabolism
March 15, 2006
Markus Laimer
,
Karin Kramer-Reinstadler
,
Markus Rauchenzauner
, et al
JCP
Original Research
Olanzapine Induces Insulin Resistance: Results From A Prospective Study
December 15, 2003
Christoph F. Ebenbichler
,
Markus Laimer
,
Ursula Eder
, et al
